0001179110-17-009109.txt : 20170615
0001179110-17-009109.hdr.sgml : 20170615
20170615164336
ACCESSION NUMBER: 0001179110-17-009109
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170613
FILED AS OF DATE: 20170615
DATE AS OF CHANGE: 20170615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEPOMED INC
CENTRAL INDEX KEY: 0001005201
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943229046
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD.
STREET 2: SUITE 300
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-744-8000
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD.
STREET 2: SUITE 300
CITY: NEWARK
STATE: CA
ZIP: 94560
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vargas Thadd M
CENTRAL INDEX KEY: 0001529033
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13111
FILM NUMBER: 17913943
MAIL ADDRESS:
STREET 1: 1360 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
edgar.xml
FORM 4 -
X0306
4
2017-06-13
0
0001005201
DEPOMED INC
DEPO
0001529033
Vargas Thadd M
C/O DEPOMED, INC.
7999 GATEWAY BOULEVARD, SUITE 300
NEWARK
CA
94560
0
1
0
0
SVP, Business Development
Common Stock
2017-06-13
4
S
0
21751
9.587
D
19816
D
Common Stock
2017-06-13
4
S
0
19816
9.60
D
0
D
Common Stock
2017-06-13
4
M
0
19320
7.12
A
19320
D
Common Stock
2017-06-13
4
M
0
45000
6.08
A
64320
D
Common Stock
2017-06-13
4
M
0
43000
6.11
A
107320
D
Common Stock
2017-06-13
4
M
0
53500
6.77
A
160820
D
Common Stock
2017-06-13
4
S
0
160820
9.526
D
0
D
Common Stock
7.12
2017-06-13
4
M
0
19320
0
D
2021-01-14
Common Stock
19320
0
D
Common Stock
6.08
2017-06-13
4
M
0
45000
0
D
2021-09-01
Common Stock
45000
0
D
Common Stock
6.11
2017-06-13
4
M
0
43000
0
D
2022-01-12
Common Stock
43000
0
D
Common Stock
6.77
2017-06-13
4
M
0
53500
0
D
2023-02-07
Common Stock
53500
0
D
Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.
The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote.
19,320 stock options were granted on January 14, 2011 and were exercisable in 48 equal monthly installments.
45,000 stock options were granted on September 1, 2011 and were exercisable in 48 equal monthly installments.
43,000 stock options were granted on January 12, 2012 and were exercisable in 48 equal monthly installments.
53,500 stock options were granted on February 7, 2013 and were exercisable in 48 equal monthly installments.
/s/ Thadd M. Vargas
2017-06-14